[Pharmacological correction of cochleovestibular impairments].
Pal'chun
V T
VT
Poliakova
T S
TS
Kunel'skaia
N A
NA
Bogdanets
S A
SA
D000328:Adult; D000367:Age Factors; D001621:Betahistine / Q000008:administration & dosage / Q000627:therapeutic use; D015834:Cochlear Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D020441:Ginkgo biloba; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009278:Naphazoline / Q000008:administration & dosage / Q000627:therapeutic use; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use; D008517:Phytotherapy; D010936:Plant Extracts / Q000008:administration & dosage / Q000627:therapeutic use; D012737:Sex Factors; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015837:Vestibular Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000096983:Ginkgo Extract
D001621:Betahistine; D009278:Naphazoline; D010431:Pentoxifylline; D010936:Plant Extracts; D014665:Vasodilator Agents; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract